BDKRB2 and hypertensive disorder: rs8012552 of BDKRB2 was significantly associated with height (p-value = 0.003), LVH on ECHO (p-value = 0.03), total protein (p-value = 0.035), calcium channel blockers (CCBs) (p-value = 0.029), the number of HTN drugs from all classes (p-value = 0.02) and the number of required HTN drugs (p-value = 0.027).